Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy
By Allison DeAngelis and Elaine Chen May 23, 2024 for Stat News Enticed by the immense market opened by GLP-1 weight loss
Read MoreBy Allison DeAngelis and Elaine Chen May 23, 2024 for Stat News Enticed by the immense market opened by GLP-1 weight loss
Read MoreBy Rylee Wilson on May 21, 2024 for Becker’s Healthcare More hospitals are cutting ties with Medicare Advantage plans, and
Read MoreBy Suzanne Blake on May 22, 2024 for Newsweek Millennials are worried Medicare won’t be around for them when they
Read MoreBy Chris Pope on May 20, 2024 for City Journal In 2023, Medicare spent an average of $16,710 on health-care benefits
Read MoreBy Renuka Rayasam on May 21, 2024 for KFF Health News The makers of Ozempic and Mounjaro charge list prices
Read MoreBy Suzanne Blake on May 18, 2024 for Newsweek Medicare Advantage patients may be in for a rude awakening as
Read MoreBy Paul Anuzis on May 18, 2024 for Daily Independent When President Joe Biden took office, he embarked on a
Read More(By Phil Galewitz for KFF Health News HOUSTON — Patients admitted to Houston Methodist Hospital get a monitoring device about
Read More(By Erica Carbajal for Becker’s Hospital Review) New research has found that nearly all people with two copies of the gene variant
Read MorePublished by 1A on April 24, 2024 for NPR When we began our retirement series a couple months ago, there
Read More